Immorta Bio Publishes Over 70% Increased Longevity in Aging Animals by its Patented Therapeutic Combination

Peer-Reviewed Study Demonstrates the Essential Role of Senolytic Immunotherapy in Unleashing Anti-Aging Potential of Stem Cells MIAMI and SAN DIEGO, June 11, 2026 /PRNewswire/ — Immorta Bio, a scientific longevity biotechnology company focused on Treating Diseases of Aging and Treating…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks